Alphatec Holdings CFO John Koning buys $99,146 in common stock
On November 16, 2026, Alphatec Holdings' CFO John Koning made a notable investment in the company's own common stock, acquiring 14,601.7699 shares at a price of $6.79 per share. This transaction amounted to a total of approximately $99,146, bringing Koning's total holdings to 615,322.7699 shares of Alphatec Holdings common stock.
Analysts believe the stock is currently undervalued, trading near its 52-week low of $6.71, with a significant 67% decline year-to-date, yet shows potential for upside appreciation. Notably, Alphatec Holdings' performance in the third quarter of 2026 fell short of Wall Street's expectations, with adjusted earnings of $0.09 per share, below the anticipated $0.10, and revenue of $221.17 million, missing the forecasted $225.44 million.
Despite a 13% year-over-year revenue increase, weaker biologics sales and a reduced full-year outlook posed challenges. Analyst firms TD Cowen and Needham lowered their price targets for the company to $10 and $12, respectively, while maintaining a Buy rating. However, TD Cowen cited intensified biologics headwinds and a market slowdown as factors for their adjustment, while Needham's decision was influenced by the revenue miss and revised financial guidance.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Why is PROG Holdings stock sliding today? investing.com